Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.2 USD | -0.49% | -1.74% | +17.82% |
05:02pm | Merck: encouraging results in gastric cancer | CF |
01/05 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.82% | 326B | |
+29.81% | 699B | |
+25.07% | 571B | |
-4.77% | 364B | |
+3.46% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.77% | 154B | |
-3.64% | 149B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Company's Supplemental Biologics License Application for Vaxneuvance Gets FDA Priority Review